Acorda Jumps as Parkinson???s Drug Performs Well in Late-Stage Study

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks5.jpg" NAME"Acorda Jumps as Parkinsons Drug Performs Well in Late-Stage Study" ALT"Acorda Jumps as Parkinsons Drug Performs Well in Late-Stage Study"June 6, 2017By Alex Keown, BioSpace.com Breaking News Staff<BR...…

Continue ReadingAcorda Jumps as Parkinson???s Drug Performs Well in Late-Stage Study

Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It" ALT"Loxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who…

Continue ReadingLoxo Oncology Seeks FDA Approval After Breakthrough Drug Larotrectinib Helped Almost Everyone Who Took It

Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free" ALT"Investors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple…

Continue ReadingInvestors Sigh With Relief as bluebird bio, Celgene's CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free